| Pca Type |
Index Name |
Unit |
Stratification |
Effect Index (crude) |
P-value (crude) |
Effect Index (Adjusted) |
P-value (Adjusted) |
Advanced PCa | C-peptide distribution | pmol/L | 1367-2016 | NA | NA | 1.50,0.47,4.82 | NA | Advanced PCa | C-peptide distribution | pmol/L | 49-1366 | NA | NA | 1.39,0.47,4.09 | NA | Advanced PCa | C-peptide distribution | pmol/L | <849 | NA | NA | 1 | NA | Advanced PCa | C-peptide distribution | pmol/L | ≥2017 | NA | NA | 1.83,0.50,6.78 | NA | High grade PCa | C-peptide distribution | pmol/L | 1367-2016 | NA | NA | 0.32,0.11,0.97 | NA | High grade PCa | C-peptide distribution | pmol/L | 49-1366 | NA | NA | 1.00,0.37,2.68 | NA | High grade PCa | C-peptide distribution | pmol/L | <849 | NA | NA | 1 | NA | High grade PCa | C-peptide distribution | pmol/L | ≥2017 | NA | NA | 0.57,0.18,1.83 | NA | Local PCa | C-peptide distribution | pmol/L | 1367-2016 | NA | NA | 0.50,0.24,1.05 | NA | Local PCa | C-peptide distribution | pmol/L | 49-1366 | NA | NA | 0.77,0.361,1.66 | NA | Local PCa | C-peptide distribution | pmol/L | <849 | NA | NA | 1 | NA | Local PCa | C-peptide distribution | pmol/L | ≥2017 | NA | NA | 0.44,0.19,1.03 | NA | Low grade PCa | C-peptide distribution | pmol/L | 1367-2016 | NA | NA | 0.92,0.44,1.91 | NA | Low grade PCa | C-peptide distribution | pmol/L | 49-1366 | NA | NA | 1.13,0.56,2.31 | NA | Low grade PCa | C-peptide distribution | pmol/L | <849 | NA | NA | 1 | NA | Low grade PCa | C-peptide distribution | pmol/L | ≥2017 | NA | NA | 0.68,0.30,1.54 | NA | Total PCa | C-peptide distribution | pmol/L | 1367-2016 | NA | NA | 0.66,0.39,1.10 | NA | Total PCa | C-peptide distribution | pmol/L | 49-1366 | NA | NA | 0.92,0.57,1.49 | NA | Total PCa | C-peptide distribution | pmol/L | <849 | NA | NA | 1 | NA | Total PCa | C-peptide distribution | pmol/L | ≥2017 | NA | NA | 0.65,0.37,1.14 | NA | Total PCa | C-peptide+Age>71 | pmol/L | 1367-2016 | NA | NA | 0.46,0.21,1.01 | NA | Total PCa | C-peptide+Age>71 | pmol/L | 49-1366 | NA | NA | 0.77,0.37,1.62 | NA | Total PCa | C-peptide+Age>71 | pmol/L | <849 | NA | NA | 1 | NA | Total PCa | C-peptide+Age>71 | pmol/L | ≥2017 | NA | NA | 0.51,0.22,1.19 | NA | Total PCa | C-peptide+Age≤71 | pmol/L | 1367-2016 | NA | NA | 0.91,0.43,1.92 | NA | Total PCa | C-peptide+Age≤71 | pmol/L | 49-1366 | NA | NA | 1.06,0.54,2.07 | NA | Total PCa | C-peptide+Age≤71 | pmol/L | <849 | NA | NA | 1 | NA | Total PCa | C-peptide+Age≤71 | pmol/L | ≥2017 | NA | NA | 0.70,0.30,1.62 | NA | Total PCa | C-peptide+Body mass index(BMI)<26.5 | pmol/L | 1367-2016 | NA | NA | 0.59,0.30,1.17 | NA | Total PCa | C-peptide+Body mass index(BMI)<26.5 | pmol/L | 49-1366 | NA | NA | 0.75,0.40,1.43 | NA | Total PCa | C-peptide+Body mass index(BMI)<26.5 | pmol/L | <849 | NA | NA | 1 | NA | Total PCa | C-peptide+Body mass index(BMI)<26.5 | pmol/L | ≥2017 | NA | NA | 0.64,0.32,1.28 | NA | Total PCa | C-peptide+Body mass index(BMI)>26.5 | pmol/L | 1367-2016 | NA | NA | 0.85,0.40,1.81 | NA | Total PCa | C-peptide+Body mass index(BMI)>26.5 | pmol/L | 49-1366 | NA | NA | 1.25,0.60,2.57 | NA | Total PCa | C-peptide+Body mass index(BMI)>26.5 | pmol/L | <849 | NA | NA | 1 | NA | Total PCa | C-peptide+Body mass index(BMI)>26.5 | pmol/L | ≥2017 | NA | NA | 0.95,0.45,2.01 | NA |
